These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10099427)

  • 1. Serum increases the CD13 receptor expression, reduces the transduction of fluid-mechanical forces, and alters the metabolism of HL60 cells cultured in agitated bioreactors.
    McDowell CL; Papoutsakis ET
    Biotechnol Bioeng; 1998 Oct; 60(2):259-68. PubMed ID: 10099427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methocel A15LV, polyethylene glycol, and polyvinyl alcohol on CD13 and CD33 receptor surface content and metabolism of HL60 cells cultured in stirred tank bioreactors.
    McDowell CL; Carver RT; Papoutsakis ET
    Biotechnol Bioeng; 1998 Oct; 60(2):251-8. PubMed ID: 10099426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased agitation intensity increases CD13 receptor surface content and mRNA levels, and alters the metabolism of HL60 cells cultured in stirred tank bioreactors.
    McDowell CL; Papoutsakis ET
    Biotechnol Bioeng; 1998 Oct; 60(2):239-50. PubMed ID: 10099425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreasing extracellular pH increases CD13 receptor surface content and alters the metabolism of HL60 cells cultured in stirred tank bioreactors.
    McDowell CL; Papoutsakis ET
    Biotechnol Prog; 1998; 14(4):567-72. PubMed ID: 9694677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid-mechanical forces in agitated bioreactors reduce the CD13 and CD33 surface protein content of HL60 cells.
    Lakhotia S; Bauer KD; Papoutsakis ET
    Biotechnol Bioeng; 1993 Apr; 41(9):868-77. PubMed ID: 18609635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culture of human T cells in stirred bioreactors for cellular immunotherapy applications: shear, proliferation, and the IL-2 receptor.
    Carswell KS; Papoutsakis ET
    Biotechnol Bioeng; 2000 May; 68(3):328-38. PubMed ID: 10745201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal-mediated down-regulation of CD13 in bone marrow cells originating from acute myeloid leukemia patients.
    Dybkaer K; Olesen G; Pedersen FS; Kristensen JS
    Eur J Haematol; 2001 Mar; 66(3):168-77. PubMed ID: 11350485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The protective effect of serum against hydrodynamic damage of hybridoma cells in agitated and surface-aerated bioreactors.
    Kunas KT; Papoutsakis ET
    J Biotechnol; 1990 Jul; 15(1-2):57-69. PubMed ID: 1366688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agitation increases expansion of cord blood hematopoietic cells and promotes their differentiation into myeloid lineage.
    Hosseinizand H; Ebrahimi M; Abdekhodaie MJ
    Cytotechnology; 2016 Aug; 68(4):969-78. PubMed ID: 26264594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes.
    Gabrilovac J; Cupić B; Breljak D; Zekusić M; Boranić M
    Immunol Lett; 2004 Jan; 91(1):39-47. PubMed ID: 14757368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damaging agitation intensities increase DNA synthesis rate and alter cell-cycle phase distributions of CHO cells.
    Lakhotia S; Bauer KD; Papoutsakis ET
    Biotechnol Bioeng; 1992 Oct; 40(8):978-90. PubMed ID: 18601205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ubenimex (Bestatin) on the cell growth and phenotype of HL-60 and HL-60R cell lines: up-and down-regulation of CD13/aminopeptidase N.
    Imamura N; Kimura A
    Leuk Lymphoma; 2000 May; 37(5-6):663-7. PubMed ID: 11042531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of CD40 in promyelocytic HL60 cells cultured with retinoic acid and/or various cytokines.
    Shinagawa T; Nunoi H; Nonoyama S; Kanegasaki S
    J Biochem; 1995 Sep; 118(3):534-40. PubMed ID: 8690713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of CD13 expression during retinoic acid-induced differentiation of HL60 cells.
    Razak K; Allen PD; Kelsey SM; Gutteridge CN; Newland AC
    Leuk Res; 1994 Aug; 18(8):629-36. PubMed ID: 7914950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An actively mixed mini-bioreactor for protein production from suspended animal cells.
    Diao J; Young L; Zhou P; Shuler ML
    Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K; Natazuka T; Chihara K; Kitazawa F; Tsumura A; Takara K; Nomiyama M; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 1996; 37(4):297-304. PubMed ID: 8548874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotenone, a mitochondrial NADH dehydrogenase inhibitor, induces cell surface expression of CD13 and CD38 and apoptosis in HL-60 cells.
    Matsunaga T; Kudo J; Takahashi K; Dohmen K; Hayashida K; Okamura S; Ishibashi H; Niho Y
    Leuk Lymphoma; 1996 Feb; 20(5-6):487-94. PubMed ID: 8833408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of culture conditions, culture media volumes, and glucose content on metabolic properties of renal epithelial cell cultures. Are renal cells in tissue culture hypoxic?
    Gstraunthaler G; Seppi T; Pfaller W
    Cell Physiol Biochem; 1999; 9(3):150-72. PubMed ID: 10494029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) on the HL-60 cell line by TGF-beta(1).
    Gabrilovac J; Breljak D; Cupić B
    Int Immunopharmacol; 2008 May; 8(5):613-23. PubMed ID: 18387503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
    Kehlen A; Göhring B; Langner J; Riemann D
    Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.